Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism

Albinism, caused by a deficiency of melanin pigment in the skin, hair, and eye (oculocutaneous albinism [OCA]), or primarily in the eye (ocular albinism [OA]), results from mutations in genes involved in the biosynthesis of melanin pigment. The lack of melanin pigment in the developing eye leads to fovea hypoplasia and abnormal routing of the optic nerves. These changes are responsible for the nystagmus, strabismus, and reduced visual acuity common to all types of albinism. Mutations in six genes have been reported to be responsible for different types of oculocutaneous and ocular albinism, including the tyrosinase gene (TYR) and OCA1 (MIM# 203100), the OCA2 gene and OCA2 (MIM# 203200), the tyrosinase‐related protein‐1 gene (TYRP1) and OCA3 (MIM# 203290), the HPS gene and Hermansky‐Pudlak syndrome (MIM# 203300), the CHS gene (CHS1), and Chediak‐Higashi syndrome (MIM# 214500), and the X‐linked ocular albinism gene and OA1 (MIM#300500). The function of only two of the gene products is known tyrosinase and tyrosinase‐related protein‐1 both of which are enzymes in the melanin biosynthetic pathway. Continued mutational analysis coupled with function/structure studies should aid our understanding of the function of the remaining genes and their role in albinism. Mutation and polymorphism data on these genes are available from the International Albinism Center Albinism Database web site (http://www.cbc.umn.edu/tad). Hum Mutat 13:99–115, 1999. © 1999 Wiley‐Liss, Inc.

[1]  D. Bennett,et al.  Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes. , 1998, Experimental cell research.

[2]  E. Kuehl,et al.  Three new mutations in a gene causing Hermansky-Pudlak syndrome: clinical correlations. , 1998, Molecular genetics and metabolism.

[3]  M. Brilliant,et al.  Identification of a novel transcript produced by the gene responsible for the Hermansky-Pudlak syndrome in Puerto Rico. , 1998, The Journal of investigative dermatology.

[4]  E. Kuehl,et al.  Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). , 1998, The New England journal of medicine.

[5]  K. Kidd,et al.  OA1 mutations and deletions in X-linked ocular albinism. , 1998, American journal of human genetics.

[6]  R. Spritz,et al.  Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. , 1998, American journal of human genetics.

[7]  M. Ramsay,et al.  Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. , 1997, American journal of human genetics.

[8]  J. White,et al.  Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. , 1997, American journal of human genetics.

[9]  C. A. Ramsden,et al.  Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.

[10]  R. Spritz,et al.  Mutational analysis of copper binding by human tyrosinase. , 1997, The Journal of investigative dermatology.

[11]  R. Spritz,et al.  Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein. , 1997, Human molecular genetics.

[12]  S. Kingsmore,et al.  Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. , 1997, Human molecular genetics.

[13]  R. Spritz,et al.  Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene. , 1997, The Journal of investigative dermatology.

[14]  Richard A. Spritz,et al.  Positional cloning of a gene for Hermansky–Pudlak syndrome, a disorder of cytoplasmic organelles , 1996, Nature Genetics.

[15]  A. Ballabio,et al.  The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Lovett,et al.  Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.

[17]  R. Sturm,et al.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". , 1996, American journal of human genetics.

[18]  C. Summers,et al.  Diagnosis of oculocutaneous albinism with molecular analysis. , 1996, American journal of ophthalmology.

[19]  R. Spritz,et al.  Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene. , 1996, The Journal of investigative dermatology.

[20]  V. Sheffield,et al.  Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1) , 1996, Ophthalmic genetics.

[21]  M. Jay,et al.  A trinucleotide deletion together with a base duplication event at codon 439 in the human tyrosinase gene identifies a mutational hotspot. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[22]  J. White,et al.  A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. , 1995, American journal of human genetics.

[23]  M. Brilliant,et al.  Melanosomal tyrosine transport in normal and pink-eyed dilution murine melanocytes. , 1995, Pigment cell research.

[24]  P. Parsons,et al.  Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. , 1995, Genomics.

[25]  R. Spritz,et al.  Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3. , 1995, Human molecular genetics.

[26]  C. Pierach.  Book Review Reflections and Recollections from a Long Life with Medicine By Jan G. Waldenström. 137 pp. Rome, Ferrata Storti Foundation Publication, 1994. $20. 88-7002-654-X , 1995 .

[27]  R. Spritz,et al.  Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2). , 1995, American journal of human genetics.

[28]  A. Ballabio,et al.  Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome , 1995, Nature Genetics.

[29]  R. Spritz,et al.  Organization and sequence of the human P gene and identification of a new family of transport proteins. , 1995, Genomics.

[30]  E. Zackai,et al.  Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2). , 1994, Human molecular genetics.

[31]  K. Urabe,et al.  A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.

[32]  Z. Abdel‐Malek,et al.  On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[33]  M. Brilliant,et al.  African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism , 1994, Nature Genetics.

[34]  M. Jay,et al.  Initiation codon mutation of the tyrosinase gene as a cause of human albinism. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[35]  R. Spritz,et al.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel. , 1994, American journal of human genetics.

[36]  R. Spritz,et al.  Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. , 1994, The New England journal of medicine.

[37]  R. Spritz,et al.  Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA). , 1993, American journal of human genetics.

[38]  R. Spritz.  Molecular genetics of oculocutaneous albinism. , 1993, Human molecular genetics.

[39]  S. Orlow,et al.  Pathogenesis of the platinum (cp) mutation, a model for oculocutaneous albinism. , 1993, The Journal of investigative dermatology.

[40]  W. Oetting,et al.  A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual. , 1993, Human molecular genetics.

[41]  R. Spritz,et al.  A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism , 1993, Nature.

[42]  M. Farrall,et al.  The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. , 1992, American journal of human genetics.

[43]  M. Lyon,et al.  The Mouse Pink-Eyed Dilution Gene: Association with Human Prader-Willi and Angelman Syndromes , 1992, Science.

[44]  R. Spritz,et al.  Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. , 1992, American journal of medical genetics.

[45]  A. Houghton,et al.  Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization. , 1992, Genomics.

[46]  N. Copeland,et al.  A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus. , 1992, The EMBO journal.

[47]  W. Oetting,et al.  PCR detection of a TaqI polymorphism at the CCAATT box of the human tyrosinase (TYR) gene. , 1991, Nucleic acids research.

[48]  J. White,et al.  Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism. , 1991, American journal of human genetics.

[49]  R. Spritz,et al.  A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism. , 1991, Journal of medical genetics.

[50]  J. White,et al.  Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. , 1991, The Journal of investigative dermatology.

[51]  B. Kwon,et al.  A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Spritz,et al.  Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism. , 1991, American journal of human genetics.

[53]  R. Spritz,et al.  A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. , 1991, Gene expression.

[54]  R. Spritz,et al.  Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. , 1991, Genomics.

[55]  U. Francke,et al.  Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism. , 1991, American journal of human genetics.

[56]  S. Shibahara,et al.  Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. , 1990, The Journal of biological chemistry.

[57]  R. Spritz,et al.  Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism. , 1990, The New England journal of medicine.

[58]  R. Spritz,et al.  RFLP for MboI in the human tyrosinase (TYR) gene detected by PCR. , 1990, Nucleic acids research.

[59]  R. Spritz,et al.  A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Shibahara,et al.  Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. , 1990, Nucleic acids research.

[61]  A. Takeda,et al.  Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. , 1989, Biochemical and biophysical research communications.

[62]  D. Barton,et al.  Human tyrosinase gene, mapped to chromosome 11 (q14----q21), defines second region of homology with mouse chromosome 7. , 1988, Genomics.

[63]  I. Jackson,et al.  A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Marcy Krumwiede,et al.  Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky‐Pudlak syndrome , 1987, American journal of hematology.

[65]  B. Kwon,et al.  Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Hui,et al.  Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. , 1984, Blood.

[67]  A. Garner,et al.  Macromelanosomes in X‐linked ocular albinism , 1980, Histopathology.

[68]  W. Green,et al.  X-Linked Ocular Albinism: An Oculocutaneous Macromelanosomal Disorder , 1976 .

[69]  J. White,et al.  Tyrosinase positive oculocutaneous albinism among the Zuni and the Brandywine triracial isolate: biochemical and clinical characteristics and fertility. , 1972, American journal of physical anthropology.

[70]  MH Brilliant,et al.  Mutations of the human P gene associated with type II oculocutaneous albinism (OCA2) , 1998 .

[71]  W. Oetting,et al.  Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1) , 1998, Human mutation.

[72]  R. Spritz,et al.  Novel mutations of the P gene in type II oculocutaneous albinism (OCA2) , 1997, Human mutation.

[73]  R. Spritz,et al.  Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1) , 1997, Human mutation.

[74]  R. Spritz,et al.  Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. , 1997, The Journal of investigative dermatology.

[75]  M. Brilliant,et al.  Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African‐Americans , 1996 .

[76]  P. Bork,et al.  Identification and mutation analysis of the complete gene for Chediak–Higashi syndrome , 1996, Nature Genetics.

[77]  C. Summers,et al.  Analysis of tyrosinase gene mutations using direct automated infrared fluorescence DNA sequencing of amplified exons , 1994, Electrophoresis.

[78]  W. Oetting,et al.  A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. , 1993, American journal of human genetics.

[79]  W. Oetting,et al.  Molecular basis of type I (tryrosinase‐related) oculocutaneous albinism: Mutations and polymorphisms of the human tyrosinase gene , 1993 .

[80]  S. Orlow,et al.  Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis. , 1993, The Journal of investigative dermatology.

[81]  C. Summers,et al.  Visual anomalies associated with albinism. , 1990, Ophthalmic paediatrics and genetics.

[82]  J. I. Phillips,et al.  Red or rufous albinism in southern Africa. , 1990, Ophthalmic paediatrics and genetics.

[83]  V. Hearing,et al.  Mammalian tyrosinase--the critical regulatory control point in melanocyte pigmentation. , 1987, The International journal of biochemistry.

[84]  C. Witkop,et al.  Inherited disorders of pigmentation. , 1985, Clinics in dermatology.

[85]  W. Silvers.  The coat colours of mice. A model for mammalian gene action and interaction. , 1979 .

[86]  W. Silvers.  The Coat Colors of Mice , 1979, Springer New York.